Aerami Therapeutics Appoints Timm Crowder as Chief Operating Officer

NEXT STORY
Generex Biotechnology Appoints Independent Director Carol Nacy, PhD to the NuGenerex Immuno-Oncology Board of Directors
PREV STORY
Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Appoints Veteran Pharma Executive David Goren as CEO

Provides Corporate Update Including Tuberculosis Vaccine Pre-Clinical Studies and ongoing Manufacturing TestingNESS-ZIONA, ISRAEL, Sept. ...

author_avatar
NASDAQ Market News

Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call on May 5, 2016

GAITHERSBURG, Md., April 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host ...

author_avatar
NASDAQ Market News

Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome

author_avatar
NASDAQ Market News